GlassScriptPhysician profile
Giriraj Gupta
NPI 1194916213
$3,608.29
in general payments reported to CMS, 2019-2025
27 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,896 · 2020: $457 · 2021: $55.26 · 2022: $405 · 2023: $310 · 2024: $183 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,617.30 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $633.64 | 2020-2023 | Persona |
| Medtronic USA, INC. | $251.90 | 2019-2020 | |
| Si-Bone, INC. | $162.30 | 2019-2021 | |
| Spineology INC. | $138.22 | 2025 | |
| Abbvie INC. | $112.46 | 2022-2024 | |
| Medtronic, INC. | $104.83 | 2022-2025 | Cd Horizon Spinal System, Stealthstation S8 Platform |
| Pacira Pharmaceuticals Incorporated | $80.39 | 2022-2025 | Exparel |
| Amgen INC. | $54.23 | 2024-2025 | Evenity, Prolia |
| Avanos Medical | $51.82 | 2020-2023 | On-Q* Pump and Accessories |
| Integrity Implants INC. | $44.42 | 2019 | |
| Paratek Pharmaceuticals, INC. | $43.84 | 2023 | Nuzyra |
| Radius Health, INC. | $40.74 | 2019 | |
| Djo, LLC | $29.51 | 2024 | Cmf |
| Ferring Pharmaceuticals INC. | $26.76 | 2025 | Euflexxa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $26.14 | 2024 | |
| Xeris Pharmaceuticals, INC. | $22.06 | 2025 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $21.58 | 2022 | |
| Davol INC. | $21.40 | 2023 | Arista Ah Flexitip |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Bioventus LLC | $19.89 | 2019 | |
| Phathom Pharmaceuticals, INC. | $16.05 | 2024 | Voquezna |
| Depuy Synthes Sales INC. | $13.90 | 2025 | Va-Lcp |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.86 | 2021 | |
| Reprise Biomedical, INC. | $13.52 | 2025 | Miro3d |
| Axogen | $13.29 | 2019 | |
| Innocoll Pharmaceuticals Limited | $13.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giriraj Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.